Merck (MRK) announced the presentation of “positive” results from two pivotal Phase 3 trials of the investigational, once-daily, oral, two-drug ...

US pharma giant Merck & Co (NYSE: MRK) has presented positive results from two pivotal Phase III trials of the ...

Promising results from an early-stage trial suggest that lenacapavir injections might offer long-lasting protection.

American biggies are joining hands with Chinese companies. AbbVie signed a deal with Simcere Zaiming for a multiple myeloma ...

Exclusive-Merck Vaccine Case Linked to HHS Secretary ... a professor at UC Law San Francisco who specializes in legal and policy issues related to vaccines. Robi, 30, was vaccinated with Gardasil ...

Fintel reports that on March 17, 2025, HC Wainwright & Co. downgraded their outlook for Sutro Biopharma (NasdaqGM:STRO) from ...

Fintel reports that on March 14, 2025, Wedbush downgraded their outlook for Sutro Biopharma (NasdaqGM:STRO) from Outperform ...

(Reuters) - Merck and a woman suing the drugmaker agreed to halt a ... to want a delay," said Dorit Reiss, a professor at UC Law San Francisco who specializes in legal and policy issues related to ...

(Reuters) - Merck (NSE:PROR) and a woman suing the drugmaker ... a professor at UC Law San Francisco who specializes in legal and policy issues related to vaccines. Robi, 30, was vaccinated ...

being held in San Francisco and were featured in a CROI press conference. Merck plans to begin submitting applications for marketing authorization to regulatory agencies by mid-2025. In the double ...

New agents targeting endocrine therapy and CDK4/6 resistance in hormone receptor–positive breast cancer are in development.